RSLBF (RaySearch Laboratories AB) Net Interest Margin (Bank Only) %


RSLBF RaySearch Laboratories AB RSLBF
92 GF Score
Price $21.17
GF Value $20.80
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

RSLBF
92GF Score
RaySearch Laboratories AB RSLBF
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of $21.17 is trading 1.8% above its estimated GF Value™ of $20.80. GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.

Key valuation signals for RSLBF:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $20.80 vs. price of $21.17 (1.8% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
92GF Score

Get the complete analysis for RSLBF

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.17
Price
$20.80
GF Value